The Patent Finder

Terms ending in 2034

Hoffmann-La Roche Inc.

Every in-force patent on Hoffmann-La Roche Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,180,185Combination Therapy of ANTI-HER3 Antibodies
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 9,862,779Method for the Production and Selection of Molecules Comprising at Least Two Different Entities and Uses Thereof
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 9,405,069Method For Preparing An Outer Surface Of A Planar Waveguide To Be Capable Of Binding Target Samples Along A Plurality Of Predeterminded Lines And A Planar Waveguide
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 9,427,427Pharmaceutical Composition with Improved Bioavailability
In force
 · High confidence
F. Hoffmann-La Roche AGIn forceHigh confidence
US 10,034,854Pharmaceutical Composition with Improved Bioavailability
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 10,253,022Process for the Preparation of N-[(3-Aminooxetan-3-YL) METHYL]-2-(1,1-Dioxo-3,5-Dihydro-1,4-Benzothiazepin-4-YL)-6-Methyl-QUINAZOLIN-4-Amine
In force
 · Medium confidence
Hoffmann-La Roche Inc.In forceMedium confidence
US 9,925,272Anti-Theophylline Antibodies and Methods of Use
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 9,963,511Expression Vector Organization, Novel Production Cell Generation Methods and Their Use for the Recombinant Production of Polypeptides
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 9,828,340Asymmetric Synthesis of a Substituted PYRROLIDINE-2-Carboxamide
In force
 · High confidence
F. Hoffmann-La Roche AGIn forceHigh confidence
US 10,633,451Bispecific Antibody Molecules with Antigen-Transfected T-Cells and Their Use in Medicine
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
63 more term ends in 2034 · Pro
10 of 73 patents shown. Soonest term end first, then patent number.
Pro members see all 73.
Upgrade to Pro
63 of these are in force and held by Hoffmann-La Roche Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited